Imara, Inc.

Imara, Inc.

Imara, Inc.

Imara is dedicated to advancing new therapies to improve the lives of people living with sickle cell disease and other hemoglobinopathies.
Raised
$63M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
$63,000,000
Venture capital (Series B) - 2019
OrbiMed
Team Size
1–10
Employees

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Imara, Inc. makes some noise.